London, UK - 27 April 2021: Oxford Biomedica plc ( Oxford Biomedica , the Company or the Group ) (LSE:OXB), a leading gene and cell therapy group, gives notice that copies of the 2020 Annual report and accounts and the Notice of Annual General Meeting ( AGM ) have been sent to shareholders. These documents are available on the Investors section of the Group s website at www.oxb.com . Oxford Biomedica plc announced its preliminary results for the year ended 31 December 2020 on 15 April 2021. Copies of these documents have been submitted to the Financial Conduct Authority for publication through the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.